An Interview With the Food and Drug Administration About Draft Patient-Focused Drug Development Guidance 3: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments

Elisabeth M. Oehrlein, Robyn Bent, Fraser D. Bocell, Lili Garrard, Laura Lee Johnson, Naomi B. Knoble, David S. Reasner, Michelle E. Tarver 等 10 位

United States Food and Drug Administration　Duke Medical Center